title: Granulocyte accumulation in ischemic/reperfused myocardium: assessment with a technetium-99m-labeled antigranulocyte monoclonal antibody in the dog.
abstract: This study tested the usefulness of technetium-99m-labeled antigranulocyte monoclonal antibody BW250/183 (AGMAb) for identifying granulocyte accumulation in ischemic/reperfused canine myocardium. In dogs with 90 minutes coronary artery occlusion and 180 minutes reperfusion (n = 8), ischemic/reperfused myocardial samples demonstrated 8.5 +/- 2.4 times more Tc-99m-AGMAb accumulation than nonischemic samples. Dogs given Tc-99m-labeled nonspecific human immunoglobulin instead of Tc-99m-AGMAb (n = 3) had about half as much accumulation (4.5 +/- 1.6, P < .05). Ex vivo myocardial imaging of Tc-99m-AGMAb demonstrated marked uptake in infarcted regions identified by absent triphenyl tetrazolium chloride staining. The amount of uptake was inversely related to the severity of ischemia (determined by radioactive microspheres) and directly correlated with tissue myeloperoxidase activity, a specific marker of granulocyte accumulation. No increase in Tc-99m-AGMAb uptake occurred in dogs with 90 minutes ischemia and no reperfusion (n = 3) or 15 minutes ischemia and 180 minutes reperfusion (n = 2). In conclusion, Tc-99m-AGMAb is taken up in reperfused infarcted myocardium by both nonspecific and specific mechanisms. Because the amount of uptake reflects myocardial granulocyte accumulation, Tc-99m-AGMAb combined with nuclear imaging techniques may be useful for studying inflammatory processes in the heart in experimental animal models and human beings.
authors.affiliation: Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: H
authors.initials: H
authors.lastname: Takatsu
authors.forename: C M
authors.initials: CM
authors.lastname: Duncker
authors.forename: M
authors.initials: M
authors.lastname: Arai
authors.forename: L C
authors.initials: LC
authors.lastname: Becker
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D015415:Biomarkers / Q000032:analysis; D004396:Coloring Agents; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D006098:Granulocytes / Q000473:pathology*; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D007962:Leukocytes; D008297:Male; D008863:Microspheres; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000473:pathology; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000473:pathology*; D015425:Myocardial Reperfusion; D009205:Myocarditis / Q000473:pathology; D009206:Myocardium / Q000473:pathology*; D009195:Peroxidase / Q000032:analysis; D016719:Radioimmunodetection; D019275:Radiopharmaceuticals; D013778:Tetrazolium Salts; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; C104213:BW 250 183; D015415:Biomarkers; D004396:Coloring Agents; D019275:Radiopharmaceuticals; D013778:Tetrazolium Salts; C009591:triphenyltetrazolium; D009195:Peroxidase